We often assess facial skin diseases solely based on what we can see.
Is it time we looked beyond the visible?
The 2018 Beyond the Visible report provided new insights into rosacea and the burden associated with invisible symptoms. These insights further highlighted how little is really known of the burden faced by those suffering from facial skin diseases. The new 2020 report, Beyond the Visible: rosacea and psoriasis of the face, explores new dimensions of the burden faced by both rosacea and psoriasis of the face patients.
-
What more can we learn about rosacea and psoriasis of the face?
-
How are rosacea and psoriasis patients truly burdened by their facial diseases?
-
Four practical suggestions for better patient outcomes.
-
Why should we care about the burden of rosacea?
-
What does burden mean for people with rosacea?
-
What can we do to improve the lives of people with rosacea?
Contributing authors
-
Prof. Dr. Dr. Martin Steinhoff
Chairman, Dept. of Dermatology, Director, Translational Research Institute, Hamad Medical Corporation, Will Cornell University Qatar, Qatar University, Qatar
-
Dr. Julie Harper
Dermatologist at the Dermatology and Skin Care Center in Birmingham, USA
-
Prof. Dr. Uwe Gieler
Dept. of Dermatology and Clinic of Psychosomatic Medicine and Psychotherapy Justus-Liebig-University of Giessen, Germany
-
Dr. Anthony Bewley
Consultant Dermatologist, Barts Health, and Lecturer, Queen Mary College of Medicine, University of London, London, UK
-
Prof. Dr. Jerry Tan
Adjunct Professor, Western University, Windsor, Ontario, Canada
Funding and support for the survey and report provided by Galderma.
Survey was conducted by Kantar Heath, with writing support provided by Havas Life Medicom.
SOO20-03-0086a/USMP/NON/0144/0420a Date of preparation: April 2020
© 2020 Galderma S.A. All Rights Reserved. All trademarks are the property of their respective owners.
